BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18292519)

  • 1. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
    Strauss L; Bergmann C; Whiteside TL
    J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
    J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
    Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
    J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
    Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
    Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
    [No Abstract]   [Full Text] [Related]  

  • 11. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
    Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
    Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
    J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.
    Hsu LH; Li KP; Chu KH; Chiang BL
    Cell Mol Immunol; 2015 May; 12(3):354-65. PubMed ID: 25132452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
    Han Y; Guo Q; Zhang M; Chen Z; Cao X
    J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A; Brimnes MK; thor Straten P; Svane IM
    J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity.
    Hamza E; Akdis CA; Wagner B; Steinbach F; Marti E
    Clin Exp Allergy; 2013 Aug; 43(8):889-901. PubMed ID: 23889243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
    Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
    Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.